Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure
Status:
Terminated
Trial end date:
2019-02-25
Target enrollment:
Participant gender:
Summary
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in
subjects with thrombocytopenia scheduled for operations to critical sites or operations with
a high risk of bleeding.